Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 276 (TMEM276) is a poorly characterized integral membrane protein encoded by the human TMEM276 gene. Current genomic and protein prediction databases suggest TMEM276 is a membrane-associated protein that may bind zinc ions and is located in the membrane, nuclear envelope, and the perinuclear region of the cytoplasm[3]. There is no strong experimental evidence for its precise molecular or cellular function, it is not assigned to a major functional protein family (such as ion channel, transporter, receptor, or enzyme), and no data links it to specific diseases or therapeutic mechanisms. TMEM276 is part of the large TMEM (transmembrane protein) family, members of which are generally involved in a wide range of physiological processes including membrane organization and signaling; however, the specific role of TMEM276 remains to be elucidated[3][4]. No approved drugs, clinical biomarkers, or experimental mechanisms of pharmacologic action are known for TMEM276 at this time, and it is not categorized as a therapeutic target in the current literature[3][4].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 276 (TMEM276).